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Abstract
The heptahelical G protein–coupled receptors (GPCRs) belong to the largest family of cell surface
signaling receptors encoded in the human genome. GPCRs signal to diverse extracellular stimuli and
control a vast number of physiological responses, making this receptor class the target of nearly half
the drugs currently in use. In addition to rapid desensitization, receptor trafficking is crucial for the
temporal and spatial control of GPCR signaling. Sorting signals present in the intracytosolic domains
of GPCRs regulate trafficking through the endosomal-lysosomal system. GPCR internalization is
mediated by serine and threonine phosphorylation and arrestin binding. Short, linear peptide
sequences including tyrosine- and dileucine-based motifs, and PDZ ligands that are recognized by
distinct endocytic adaptor proteins also mediate internalization and endosomal sorting of GPCRs.
We present new data from bioinformatic searches that reveal the presence of these types of sorting
signals in the cytoplasmic tails of many known GPCRs. Several recent studies also indicate that the
covalent modification of GPCRs with ubiquitin serves as a signal for internalization and lysosomal
sorting, expanding the diversity of mechanisms that control trafficking of mammalian GPCRs.
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INTRODUCTION
Seven-transmembrane domain GPCRs (G protein–coupled receptors) comprise the largest
family of cell surface signaling receptors encoded in the human genome with ~900 members.
GPCRs are the targets of nearly half the drugs currently in use and for the development of new
therapeutics that can be used for the treatment of a wide range of human diseases, including
neurodegenerative, psychiatric and immune disorders, cardiovascular, gastrointestinal, renal,
and pulmonary diseases, and cancer. Upon activation, GPCRs undergo conformational changes
that facilitate activation of heterotrimeric G proteins and signaling effectors at the plasma
membrane. In addition, several internalized GPCRs can signal from endosomal compartments
through non–G protein–dependent effectors. Thus, diverse mechanisms must exist to precisely
regulate the magnitude, duration, and spatial aspects of GPCR signaling.
DISCLOSURE STATEMENT
The authors are not aware of any biases that might be perceived as affecting the objectivity of this review.
NIH Public Access
Author Manuscript
Annu Rev Pharmacol Toxicol. Author manuscript; available in PMC 2010 May 13.
Published in final edited form as:













Most activated GPCRs are rapidly desensitized at the cell surface by phosphorylation and
arrestin binding. GPCRs are then internalized but some receptors can continue to signal
independent of G proteins from such intracellular compartments. Within endosomes, GPCRs
are dephosphorylated and efficiently recycled back to the cell surface in a resensitized state in
which the receptors are competent to signal again. By contrast, other GPCRs are sorted from
endosomes to lysosomes and degraded, a process important for signal termination. Thus, GPCR
trafficking has critical functions in signal termination and propagation as well as receptor
resensitization. The rates of GPCR internalization, recycling, and lysosomal sorting differ
widely among receptors, suggesting that different mechanisms control trafficking of distinct
receptors. Indeed, several studies have revealed diverse mechanisms that regulate trafficking
of distinct GPCRs within the endosomal-lysosomal system (7,43,56,78).
The transport of GPCRs within the endosomal-lysosomal system is initiated through a series
of events that leads to deformation of select regions of the plasma membrane (Figure 1).
Clathrin-coated pits (CCPs) form at plasma membrane sites enriched in PIP2
[phosphatidylinositol (4,5)-bisphosphate] and serve as the major pathway for GPCR
internalization. Clathrin, adaptor proteins, and dozens of regulatory proteins coordinate the
assembly and invagination of CCPs, which are released from the plasma membrane by the
GTPase dynamin. Clathrin adaptor proteins recruit GPCRs to CCPs by recognizing short linear
peptide sequences as well as phosphorylated and ubiquitinated receptors (a topic recently
reviewed in Reference 1). Once internalized, GPCRs are then sorted within an early endosomal
tubulo-vesicular compartment to either a recycling or a lysosomal degradative pathway.
Sorting of GPCRs to a recycling pathway occurs through a default pathway similar to bulk
membrane flow or through a regulated process. One lysosomal sorting pathway for GPCRs
involves the ubiquitin-dependent ESCRT (endosomal-sorting complex required for transport)
machinery, which is comprised of a complex network of proteins that function coordinately to
sort ubiquitinated cargo to a degradative pathway (2). In addition, several GPCRs appear to
target to lysosomes for degradation independent of ubiquitination and some components of the
ESCRT machinery, suggesting that additional pathways exist (56,94,98). The molecular
mechanisms that regulate trafficking of mammalian GPCRs have yet to be fully elucidated and
are vital to our understanding of receptor signaling. Here, we discuss the diverse mechanisms
that regulate GPCR trafficking through the endosomal-lysosomal system.
PHOSPHORYLATION, ARRESTINS, AND GPCR TRAFFICKING
GPCR phosphorylation occurs predominantly on serine (Ser) and threonine (Thr) residues
within the C-tail and the third intracellular loop, but rarely on tyrosine (Tyr) residues. Agonist-
activated GPCRs are rapidly phosphorylated by GRKs (G protein–coupled receptor kinases)
and bind arrestins, processes that facilitate receptor uncoupling from G proteins and receptor
internalization.
The mechanism by which phosphorylation functions in GPCR trafficking is best characterized
for β2AR (β2-adrenergic receptor) internalization (Figure 2). GRK2-dependent
phosphorylation of the activated β2AR induces translocation of arrestins to the plasma
membrane where the receptor preferentially binds arrestin-3 rather than arrestin-2 (also known
as β-arrestin-2 and β-arrestin-1, respectively) (3). Once phosphorylated, activated GPCRs bind
arrestins through multiple interactions. Arrestins are comprised of distinct N and C domains
linked by a twelve-residue polar core (4), which engages receptor-associated phosphates. A
conformational change in arrestin is induced upon binding to GPCRs, exposing the C-terminal
domain, which interacts with clathrin and the β2-adaptin subunit of the clathrin adaptor AP-2
(adaptor protein complex-2), components of the endocytic machinery (5,6). The β2AR-arrestin
complex is then internalized through CCPs, and arrestin rapidly dissociates from the receptor.
Interestingly, the endocytic activity of arrestin is subject to dynamic regulation by
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dephosphorylation and ubiquitination, the latter of which occurs upon binding to activated
β2AR, as discussed below (7). Recent work also indicates that under certain conditions GRK2
activity and its ability to phosphorylate β2AR is regulated by S-nitrosylation, the covalent
attachment of nitric oxide, or S-nitrosothiols to cysteine (Cys) residues (8), providing another
level of regulation for GPCR phosphorylation.
In contrast to the β2AR, GPCRs that are phosphorylated on multiple Ser and Thr residues
positioned at the end of the C-tail bind and cointernalize with arrestins. GPCR-associated
phosphates are thought to stabilize arrestin binding by inducing a conformational change that
promotes high-affinity binding to activated receptors (9). The AT1AR (angiotensin II type 1A
receptor), V2R (vasopressin 2 receptor), and NK1R (neurokinin-1 receptor) have C-tail Ser and
Thr clusters and have been shown to internalize together with arrestins (10,11). Our
bioinformatic searches have revealed several other human GPCRs that contain clusters of Ser
and Thr residues within their C-tails (Table 1). Although arrestins engage activated and
phosphorylated GPCRs through multiple interactions, the presence of Ser and Thr clusters in
certain GPCRs may stabilize the interaction with arrestins to promote important cellular
responses. The ubiquitination status of arrestin following receptor activation also correlates
with the nature of its interaction with some GPCRs. The activation of the β2AR results in
transient ubiquitination and arrestin association, whereas other GPCRs, such as AT1AR form
stable complexes with arrestins and induce prolonged arrestin ubiquitination following agonist
exposure (12). The biological consequences of transient versus prolonged arrestin association
with GPCRs are varied. In some cases, such as the V2R, stable association with arrestin slows
receptor dephosphorylation and recycling and consequently delays resensitization (13). The
AT1AR, V2R, and NK1R bind and co-internalize together with arrestins, which facilitates
arrestins’ ability to function as a scaffold to sustain ERK-1, 2 (extracellular signal-regulated
kinase-1, 2) signaling in the cytoplasm (14,15). Arrestins also cointernalize with PAR2
(protease-activated receptor-2), a GPCR that does not recycle, and promotes sustained ERK-1,
2 signaling independently of G protein activation (16,17). Arrestins are required for
internalization of most activated GPCRs that form stable complexes with these proteins.
However, arrestins are not essential for N-formyl peptide receptor (FPR) endocytosis but
appear to regulate recycling of the FPR, suggesting a distinct endocytic function for arrestins
in receptor recycling (18). The ability of arrestins to control different aspects of GPCR signaling
and trafficking probably involves distinctly modified arrestin forms derived from differential
phosphorylation and/or ubiquitination, which have yet to be fully characterized.
In addition to the receptor, phosphorylation of critical components of the endocytic machinery
regulates GPCR trafficking. The p38 MAP (mitogen-activated protein) kinase promotes
endocytosis of the MOR (μ-opioid receptor) by directly phosphorylating EEA-1 (early
endosome antigen-1) and Rabenosyn-5, rather than the receptor (19). EEA1 and Rabenosyn-5
are effectors of the monomeric small GTP binding protein Rab5 and are involved in tethering
and fusion of early endosomes (20). Rab5 activation has also been shown to regulate trafficking
of several other GPCRs, including the β2AR and the D2 dopamine receptor (21,22), although
how this occurs mechanistically is not known. Another study recently reported that
phosphorylation of the transport machinery negatively regulates GPCR trafficking (23). CISK
(cytokine-independent survival kinase), a Ser and Thr kinase, inhibits sorting of the chemokine
receptor CXCR4 from endosomes to lysosomes by directly phosphorylating AIP4 (atrophin-
interacting protein 4), an E3 ubiquitin ligase required for CXCR4 ubiquitination and lysosomal
sorting (Figure 2) (23), as discussed further below. Thus, multiple kinases can control diverse
aspects of GPCR trafficking by phosphorylating the receptor and/or components of the
transport machinery.
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SHORT PEPTIDE SORTING SIGNALS
Increasing evidence suggests that the cytoplasmic carboxyl tails (C-tails) of GPCRs harbor
structural determinants and/or posttranslational modifications that are recognized by distinct
endocytic adaptor proteins that facilitate transport through the endocytic pathway. Short, linear
peptide sequences can mediate sorting of GPCRs within the endosomal-lysosomal system.
Some GPCRs harbor Tyr- and dileucine(Leu)-based motifs that are recognized by adaptor-
protein (AP) complexes associated with the cytosolic face of endocytic membranes. PDZ
[postsynaptic density 95-kDa protein (PSD-95), Drosophila discs large protein (DLG), and
zonula occludens-1 protein (ZO-1)] ligands are also present in the C-tail of many GPCRs and
appear to regulate critical aspects of receptor signaling and endocytic sorting (38–40).
Tyrosine- and Dileucine-Based Motifs
Several mammalian GPCRs contain C-tail Tyr- and di-Leu-based motifs that mediate receptor
trafficking (1). The clathrin adaptor AP-2 directly binds to Tyr-based motifs and regulates
mammalian GPCR internalization through CCPs. AP-2 is composed of α, β2, μ2, and σ2
subunits; the μ2 subunit recognizes Tyr-based Y-X-X-Ø motifs (where Y denotes Tyr, X is
any amino acid, and Ø is a bulky hydrophobic residue) localized within the cytosolic regions
of cargo proteins (25). The activity of this type of motif requires that the critical Tyr remain
unphosphorylated. Recent work indicates that AP-2, rather than arrestins, is required for
constitutive internalization of PAR1 (protease-activated receptor-1), a GPCR activated by
thrombin (Figure 2) (24). In the absence of agonist, PAR1 internalizes constitutively through
CCPs independently of phosphorylation and arrestin binding (26,27). Surface plasmon
resonance was used to show that the μ2-subunit of AP-2 directly binds to a distal Tyr-based
motif Y420KKL423 within the C-tail of PAR1 (24). Moreover, the expression of a PAR1
tyrosine mutant or depletion of AP-2 by siRNA significantly inhibited PAR1 constitutive
internalization. In addition to canonical Tyr-based motifs, some GPCRs contain noncanonical
sequences that appear to be regulated by AP-2. The TPβ (thromboxane-A2β) receptor contains
a related Y-X-X-X-Ø motif that functions in arrestin-independent constitutive internalization
(28). The binding pocket of the μ2-subunit of AP-2 can accommodate related Y-X-X-G-Ø
motifs (29), suggesting that it can function in TPβ endocytosis, although this remains to be
determined. AP-2 may also directly regulate activation-dependent GPCR internalization,
presumably by recruiting receptors to CCPs. The α1BAR (α1B-adrenergic receptor) binds the
μ2-subunit of AP-2 through an unusual stretch of Arg residues within the C-tail (30). Deletion
of this region ablates μ2 binding and agonist-induced internalization, although α1BAR
internalization is also dependent on arrestins (31).
Similar to AP-2, other heterotetrameric clathrin AP complexes recognize Tyr-based motifs but
have distinct functions within the endosomal-lysosomal system (25). AP-2 is abundant at
plasma membrane CCPs and mediates endocytosis. AP-1 is associated with the trans-Golgi
network and endosomal clathrin coats. AP-3 is also found on endosomes, often with clathrin.
The role of these other AP complexes in GPCR trafficking remains relatively unexplored.
However, we have identified several human GPCRs that contain canonical Tyr-based motifs
within their C-tails (Table 2), suggesting that regulation of GPCR trafficking by AP complexes
may be more common than previously appreciated. Interestingly, mutation of a critical Tyr-459
residue found within a canonical Tyr-based motif of the M2 muscarinic cholinergic receptor
C-tail impairs downregulation following prolonged agonist exposure but does not perturb
receptor internalization (32). Similarly, mutation of the PAR1 C-tail proximal Tyr-based
Y383SIL386 motif inhibits receptor degradation but has minimal effects on receptor endocytosis
(33). PAR1 has two C-tail Tyr-based motifs that appear to mediate distinct trafficking events:
The distal Y420KKL423 motif controls constitutive internalization, whereas the proximal
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Y383SIL386 motif regulates lysosomal sorting. These findings suggest that multiple motifs of
the same sorting signal within the C-tail may confer distinct endocytic functions.
In addition to Tyr-based motifs, AP complexes can recognize di-Leu motifs, which have been
implicated in mediating endocytosis of several mammalian GPCRs, including β2AR (34), and
chemokine receptors CXCR4 and CXCR2 (35,36). A CXCR2 di-Leu mutant interacts with
arrestin but fails to bind AP-2 and to internalize in response to agonist, suggesting a role for
AP-2 in di-Leu motif recognition (36). Arrestins also bind AP-2 and are likely to function
cooperatively to promote endocytosis of many GPCRs containing di-Leu motifs. However, di-
Leu-based motifs may function independent of arrestins to control endocytic sorting of other
GPCRs. Interestingly, the AP complexes also recognize acidic di-Leu [D/E]-X-X-X-L-[L/I]
motifs through α/σ2-subunit and possibly β-subunit interactions (25). Our search of human
GPCR C-tail sequences revealed several receptors that harbor acidic di-Leu motifs that
conform to both [D/E]-X-X-X-L-[L/I] and [D/E]-X-X-L-[L/I] types (Table 3), suggesting a
function in GPCR trafficking. Indeed, a recent study identified an acidic di-Leu motif within
the C-tail of the β2AR that appears to be important for controlling a regulated form of recycling
(37, see Reference 38a for further discussion).
PDZ Ligands
PDZ domains are protein-protein recognition modules that bind to C-terminal short, linear PDZ
ligand sequences that conform to type I (X-[S/T]-X-Ø), type II (X- Ø-X-Ø), or type III (X-[D/
E]-X-Ø) sequences, but they can also recognize internal sequences that structurally mimic the
C terminus (38). Although PDZ domain-containing proteins have established roles in
localization and assembly of signaling complexes, recent studies suggest that they also function
to control GPCR trafficking. In addition to the β2AR and mGluR (metabotropic glutamate
receptor), our bioinformatic searches revealed several other human GPCRs with C-terminal
type I, type II, and type III PDZ ligands (Table 4). One of the best-characterized roles for PDZ
ligands in GPCR trafficking has been demonstrated for β2AR recycling (Figure 2) (see also
38a). Briefly, the β2AR has a C-terminal DSLL motif that conforms to a type I PDZ ligand,
which controls receptor recycling (39). The β2AR PDZ ligand binds to NHERF (Na+/H+
exchanger regulatory factor)/EBP50 (ezrin/radixin/moesin-binding protein 50-kDa) family
proteins (39,40), and to NSF (N-ethylmaleimide-sensitive factor), although NSF lacks a PDZ
domain (41). A type I PDZ ligand is also found in the β1AR and is capable of promoting PDZ
domain interactions and receptor recycling (42). The β2AR displays a regulated form of
recycling that not only requires the PDZ ligand, but is also dependent on HRS (hepatocyte
growth factor–regulated tyrosine kinase substrate) (43). HRS is a modular protein that contains
an N-terminal VHS domain, an FYVE domain important for PtdIns(3)P
(phosphatidylinositol-3-phosphate) binding and endosomal localization, and an UIM
(ubiquitin-interacting motif) that binds ubiquitin (44,45). A recent study reported that a distinct
type of acidic di-Leu (E371KENLL377) motif present in the β2AR C-tail is important for both
HRS- and PDZ ligand-mediated recycling of the β2AR that requires the VHS domain (37), but
how this occurs is not known. A subset of VHS domains have been shown to bind to acidic di-
Leu motifs; however a direct interaction between the VHS domain of HRS and the acidic di-
Leu motif of the β2AR is unlikely because the VHS domain lacks the critical residues important
for binding to acidic di-Leu D-X-X-L-L motifs (46,47). In addition to C-terminal PDZ ligands,
one study has indicated that an internal PDZ ligand present in the ETA endothelin receptor C-
tail can regulate receptor recycling (48), but the endocytic sorting machinery that mediates this
process has not been identified. Interestingly, internal PDZ ligand sequences have also been
identified in several other human GPCRs (48).
In addition to recycling, PDZ ligands have been implicated in regulating endocytosis of certain
GPCRs. A recent study showed that GPCR internalization is regulated by PDZ ligand
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interactions with the actin cytoskeleton. A δ-opioid receptor chimera with a non-native PDZ
ligand sequence, as well as the β1AR and β2AR which naturally contain a PDZ ligand, displayed
prolonged cell surface resident times and reduced rates of internalization compared to non-
PDZ ligand containing GPCRs as measured by TIRF (total internal reflection fluorescence)
microscopy (49). Moreover, linking GPCRs to cortical actin by fusion of the actin-binding
domain of ezrin slowed internalization. The 5-HT2A (serotonin 5-hydroxytryptamine-2A)
receptor C-tail PDZ ligand has also been shown to mediate interaction with PSD-95 (50).
Binding of 5-HT2A to PSD-95 enhanced signaling and slowed receptor internalization,
suggesting a role in GPCR endocytosis. Another recent study reported that the P2Y1 and
P2Y12 purinergic GPCRs, which both possess type I PDZ ligands (Table 4), segregate from
each other and internalize through distinct populations of CCPs (51). Although CCPs are
known to form at preferential sites on the plasma membrane and are not likely to be induced
by overexpressed cargo (52,53), further studies are important to determine whether endogenous
GPCRs behave similarly to their ectopically expressed counterparts.
UBIQUITIN AS AN ENDOCYTIC SORTING SIGNAL
Several studies have demonstrated diverse roles for ubiquitination in regulation of mammalian
GPCR trafficking. An essential role for ubiquitination in lysosomal sorting of some mammalian
GPCRs has been previously demonstrated (7,54); in these cases ubiquitination is not required
for internalization. However, ubiquitination has been shown to function indirectly to control
endocytosis of other mammalian GPCRs (7). In yeast, ubiquitination of the Ste2 receptor
promotes internalization (55). Interestingly, a recent study has revealed a novel function for
ubiquitination in internalization of a mammalian GPCR (56).
The Ubiquitin Machinery
Modification of proteins by ubiquitin has important functions in proteasomal degradation,
transcriptional regulation, signal transduction, and trafficking within the endocytic and
biosynthetic pathways. Ubiquitin, a 76–amino acid protein, is covalently attached to proteins
through the formation of an isopeptide bond between the C-terminus of ubiquitin and the ε-
amino group of Lys residues on target proteins (Figure 3) (57). Ubiquitin contains seven Lys
residues that can serve as acceptor sites for additional ubiquitin molecules. The fate of
ubiquitinated proteins is determined in part by the length of the ubiquitin chain and on the
configuration of ubiquitin-ubiquitin linkages. Chains of four or more ubiquitins, in which the
C-terminus of one ubiquitin is attached to Lys-48 of the adjacent ubiquitin, are efficiently
targeted to the 26S proteasome for degradation. By contrast, attachment of a single ubiquitin
(mono-ubiquitination) to a target protein or attachment of ubiquitin to Lys-63 of an adjacent
ubiquitin can have distinct cellular consequences, including endocytic sorting, but not
proteasomal degradation.
The attachment of ubiquitin to substrate proteins is carried out by an ATP-dependent
mechanism that requires the sequential activity of three enzymes: E1 (ubiquitin-activating
enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin ligase) (Figure 3). The E3
ligase recognizes the substrate protein and provides specificity to the reaction, although a recent
study showed that an E2 may also function in target recognition (58). E3 ubiquitin ligases can
be divided into two major classes that contain either a HECT (homologous to E6-AP carboxyl
terminus) domain or a RING (really interesting new gene) finger domain and differ in the
mechanism by which ubiquitin is transferred to the target protein. A notable family of HECT
E3 ubiquitin ligases involved in endocytic trafficking includes the Nedd4-like E3 family, which
is comprised of nine family members (59). Rsp5, the only Nedd4 ortholog found in yeast
Saccharomyces cerevisiae, is essential for endocytosis of several transmembrane proteins but
has functions in other cellular processes (60). In contrast to the HECT domain E3s, the RING
finger E3 ubiquitin ligases lack intrinsic catalytic activity and do not form a direct thiolester
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intermediate with ubiquitin but transfer ubiquitin to the target protein indirectly via the E2
(Figure 3) (61). The RING finger E3 ligase family is comprised of several hundred members
that exist as single subunit E3s, including the MDM2 (mouse double minute-2) and Cbl (casitas
B-cell lineage) proteins as well as multi-subunit E3s, including the SCF (Skp1-Cul1-F-box)
proteins (62). E3 ligases in both classes mediate the ubiquitination of a diverse set of proteins
involved in endosomal-lysosomal sorting of membrane proteins (63).
Ubiquitin-conjugation of proteins is a highly dynamic and reversible process. DUBs
(deubiquitinating enzymes) are proteases that specifically cleave the isopeptide bond that links
ubiquitin chains and ubiquitin protein conjugates. A large and diverse family of DUBs,
comprised of ~90 functional members, are encoded in the human genome (64). In general,
deubiquitination of substrate proteins by UCHs (ubiquitin carboxyl terminal hydrolases) is
important for recycling ubiquitin from substrate proteins before degradation. In contrast, USPs
(ubiquitin-specific proteases) are likely to recognize specific substrate proteins and serve
important functions in modulating activity of proteins, some of which are directly involved in
protein trafficking. A Drosophila deubiquitinating enzyme Fat facets/USP9X has been shown
to regulate Delta/Notch receptor internalization by deubiquitinating Liquid facets, a homologue
of epsin, a component of the clathrin-endocytic machinery (65). Two other deubiquitinating
enzymes, UBPY/USP8 and AMSH (associated-molecule with the SH3 domain of STAM),
interact with STAM (signal transducing adaptor molecule), an endosomal adaptor protein that
binds to HRS to control the rate of EGFR lysosomal sorting and degradation (66,67). Moreover,
some DUBs are complexed with E3 ubiquitin ligases and appear to regulate E3 activity and
stability in addition to substrate proteins, adding another level of complexity to ubiquitin-
dependent regulation of protein trafficking (68,69).
Ubiquitin As an Internalization Signal
In yeast, GPCR internalization is mediated by direct ubiquitination. Upon activation, Ste2 and
Ste3 receptors are phosphorylated and rapidly ubiquitinated (55,70). Studies using yeast strains
that lack specific ubiquitin-conjugating enzymes and ubiquitin defective-Ste2 mutants indicate
that ubiquitination is both necessary and sufficient for constitutive and agonist-induced
receptor internalization (55,71). Although a single ubiquitin moiety appears to be sufficient to
drive Ste2 internalization (71), the attachment of short ubiquitin chains to Lys-63 of an adjacent
ubiquitin facilitates endocytosis of many integral membrane proteins (72). The ubiquitin
moiety on receptors serves as an internalization signal by binding to UBDs (ubiquitin-binding
domains) of endocytic adaptor proteins and thereby facilitates transport through the endocytic
pathway (for more information on UBDs, see the sidebar Ubiquitin-Binding Domains). Yeast
do not express arrestin proteins. Instead, the clathrin adaptors Ent1 and Ent2 (epsin homologs)
and Ede1 (eps15 homolog) harbor UBDs that recognize the ubiquitinated Ste2 receptor and
facilitate internalization (73).
Recent work has revealed a direct role for ubiquitination in the regulation of mammalian GPCR
internalization (56). PAR1 appears to be ubiquitinated under basal conditions and
deubiquitinated following activation (Figure 2). Constitutive internalization of an ubiquitin-
deficient PAR1 lysine-less mutant is enhanced, whereas fusion of ubiquitin to the C-tail of
ubiquitin-deficient PAR1 inhibited constitutive internalization. These findings suggest that
ubiquitination negatively regulates PAR1 constitutive internalization. Moreover, the major
sites of PAR1 ubiquitination occur at the highly conserved Lys-421 and Lys-422 residues
localized within the C-tail Tyr-based motif, the critical binding site of the μ2 subunit of AP-2
(24,56). These findings suggest that ubiquitination of PAR1 may preclude AP-2 binding. These
studies further demonstrate that ubiquitination of PAR1 specifies a distinct clathrin adaptor
requirement for activated receptor internalization that functions independent of arrestins and
AP-2.
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Ubiquitin-binding domains (UBDs) are a large class of protein modules that bind
noncovalently to ubiquitin or polyubiquitin chains and include UIM, CUE, UBA, VHS,
GAT, NZF, PAZ, UEV, and GLUE domains (115). UBDs are structurally diverse and vary
in length from 20 to 150 amino acids; however, most bind to a critical hydrophobic patch
on ubiquitin, which centers on the Ile-44 (115). UBDs are found in hundreds of proteins
and many proteins carry multiple copies of UBDs. The binding of UBDs to ubiquitin is
generally moderate to weak, with apparent dissociation constants in the micromolar range,
but it is biologically relevant and allows for dynamic assembly and disassembly of protein
complexes. Several proteins involved in endocytic sorting contain UBDs and are themselves
ubiquitinated, including HRS, TSG101, epsin, and eps15, thereby providing a complex level
of regulation in the transport process. HRS is the only ubiquitinated adaptor protein that
contains UBDs and functions in mammalian GPCR trafficking (43,78,116), but others await
discovery.
Ubiquitin-Dependent Targeting to Lysosomes
Sorting of ubiquitinated cargo from early endosomes to lysosomes involves transit through a
unique endosomal compartment that contains intralumenal vesicles, termed the MVBs
(multivesicular bodies). MVBs fuse with lysosomes, resulting in the degradation of lipids and
proteins (Figure 2). The ESCRT machinery that mediates sorting of ubiquitinated
transmembrane proteins was originally discovered in Saccharomyces cerevisiae using genetic
screens to identify proteins involved in sorting of biosynthetic and endocytic cargo to the
vacuole/lysosome (2). The ESCRT machinery is conserved in mammalian cells, although
mammalian cells have a greater diversity and specialization in endocytic sorting pathways.
HRS is recruited to endosomes in part via its FYVE domain, which binds to PtdIns(3)P, a lipid
enriched on endosomal membranes. HRS recruits clathrin to discrete microdomains that form
flat clathrin lattices on endosomal membranes where proteins destined for degradation are
concentrated (45,74). HRS binds directly to ubiquitinated cargo on endosomes and to TSG101,
a component of ESCRT-I. ESCRT-II and -III complexes are then recruited sequentially to
endosomes and act downstream of ESCRT-I (a topic recently reviewed in 75). The ESCRT
complexes function together to coordinate the recruitment and sorting of ubiquitinated cargo
and MVB formation. Cargo is then deubiquitinated before entry into MVBs. The activity of
VPS4 (vacuolar protein sorting), an AAA-ATPase that catalyzes the disassembly of the ESCRT
components, is also important for sorting cargo into the MVB and for the formation of
intralumenal vesicles (76,77). In addition to transmembrane proteins in yeast, several
mammalian GPCRs are targeted to lysosomes through an ubiquitin- and ESCRT-dependent
mechanism.
The β2AR was the first mammalian GPCR shown to undergo agonist-dependent ubiquitination
and receptor degradation (Figure 2) (7). A β2AR mutant receptor in which all Lys residues
were converted to Arg internalized normally but failed to downregulate, as measured by a loss
in the number of receptor binding sites following prolonged agonist exposure. Interestingly,
activation of the β2AR results in rapid ubiquitination, which peaks within 1 h but is considerably
diminished by 2 h, although a significant loss in receptor binding sites is not detectable until
much later. The mechanistic basis for the delay in β2AR degradation following ubiquitination
is not known. Agonist-induced ubiquitination of the β2AR requires phosphorylation and
arrestin binding. A mutant β2AR defective in PKC and GRK phosphorylation sites, which does
not bind arrestins, fails to undergo agonist-promoted ubiquitination and degradation,
suggesting that arrestins are critical for activated receptor ubiquitination (7). Indeed, agonist-
induced β2AR ubiquitination is lost in arrestin-3 null mouse embryonic fibroblasts and restored
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upon arrestin-3, but not arrestin-2, expression (7). Interestingly, ubiquitination of arrestin-3 by
the E3 ubiquitin ligase MDM2 is essential for β2AR internalization; however, MDM2 is not
responsible for β2AR ubiquitination. These studies establish an important role for arrestin-3 in
β2AR ubiquitination and degradation but the E3 ubiquitin ligase and endocytic sorting
machinery that mediate ubiquitin-dependent lysosomal degradation of the β2AR have yet to
be identified.
The mechanism by which ubiquitination regulates lysosomal sorting and degradation of a
mammalian GPCR is best understood for CXCR4. Activated CXCR4 is rapidly ubiquitinated,
sorted to lysosomes and degraded within hours (Figure 2) (54). Sorting of activated CXCR4
to lysosomes is mediated by ubiquitination of Lys residues within a C-
tail 324SSLKILSKGK333 degradation motif. The HECT domain Nedd4-like E3 ubiquitin ligase
AIP4, also known as Itch, colocalizes with CXCR4 at the plasma membrane and mediates
receptor ubiquitination upon agonist stimulation (78). Interestingly, mutation of Ser residues
within the putative degradation motif attenuates agonist-promoted CXCR4 degradation,
suggesting that phosphorylation functions in receptor ubiquitination.
Although ubiquitination of CXCR4 occurs at the plasma membrane, it functions as an
endosomal sorting signal to facilitate CXCR4 transport to MVBs and degradation (23,78).
Activated CXCR4 colocalizes with HRS and the E3 ligase AIP4 on endosomal microdomains
(78). Interestingly, AIP4 not only ubiquitinates CXCR4 but also mediates HRS ubiquitination
following agonist exposure, suggesting that ubiquitination of HRS is important for CXCR4
endosomal sorting. Moreover, the endosomal function of AIP4 is negatively regulated by
phosphorylation mediated by CISK (23), a Ser/Thr kinase activated downstream of PI
(phosphoinositide)-3-kinase. CISK colocalizes with AIP4 on endosomal membranes and
phosphorylates specific residues within the WW domains of AIP4 (23). The mechanism by
which phosphorylation impairs the ability of AIP4 to facilitate CXCR4 lysosomal sorting is
not known, but may involve disruption of the capacity of AIP4 to recognize, and ubiquitinate
target proteins (23). Finally, CXCR4 deubiquitination and activity of the ATPase of VPS4 is
required for efficient lysosomal sorting and degradation (78). A VPS4 mutant that prevents
disassembly and release of the ESCRT complexes from endosomal membranes blocks CXCR4
degradation (78). Moreover, the abundance of ubiquitinated CXCR4 and HRS species are
increased considerably when VPS4 activity is disrupted, suggesting that deubiquitination of
CXCR4 and HRS is important for efficient lysosomal sorting and degradation. Consistent with
this observation, the deubiquitinating enzyme AMSH directly binds to the CaR (calcium-
sensing receptor) C-tail and enhances agonist-induced receptor degradation (79), suggesting
that the deubiquitination of CaR and/or an adaptor protein is important for lysosomal
degradation.
In addition to the β2AR and CXCR4, many other GPCRs are modified with ubiquitin and
degraded in an agonist-dependent manner, suggesting a more general role for ubiquitination
in GPCR trafficking. Indeed, activation induces ubiquitination and degradation of the V2R
(80), sst3 somatostatin receptor (81), PAR2 (82), NK1R (83), and the S1P (sphingosine 1-
phosphate) receptor (84). Although the PAFR (platelet-activating factor receptor) is basally
ubiquitinated, agonist-promoted PAFR degradation may require ubiquitination (85). PAR2
ubiquitination and lysosomal sorting appears to be regulated by c-Cbl, an E3 RING finger
ubiquitin ligase (82). A deletion mutant of c-Cbl lacking the RING finger domain acts as a
dominant-negative and inhibits activated PAR2 ubiquitination and degradation. Ubiquitination
of activated PAR2 by c-Cbl appears to be mediated by a Src-dependent mechanism, but whether
PAR2 directly binds to c-Cbl or requires an intermediate protein is not known.
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UBIQUITIN AND TRAFFICKING THROUGH THE BIOSYNTHETIC PATHWAY
GPCR ubiquitination also has an important role in quality control during biosynthesis and
functions to sort misfolded receptors to the ERAD [endoplasmic reticulum (ER)-associated
protein degradation] pathway that involves degradation by the proteasome, a large multiprotein
complex localized in the cytoplasm or nucleus. Polyubiquitination and degradation of
misfolded GPCRs by the proteasome has been demonstrated for the δ-opioid receptor (86),
rhodopsin (87,88), TRHR (thyrotropin-releasing hormone receptor) (89), and the CaR (90).
The E3 ubiquitin ligase dorfin (double-RING finger protein) binds to the C-tail of the CaR to
possibly mediate its ubiquitination and degradation by the proteasome during biosynthesis.
Siah1A (seven in absentia homolog 1A), a RING finger E3 ubiquitin ligase, mediates
ubiquitination and degradation of the long splice forms of mGluR1 and mGluR5 (91), but
whether this occurs through a proteasomal or lysosomal pathway has not been clearly
established. Ubiquitination of the FSHR (follitropin receptor) appears to regulate cell surface
expression but does not affect the rate of FSHR internalization (92), suggesting a function in
trafficking through the biosynthetic pathway. In addition to ubiquitination, deubiquitination of
GPCRs during biosynthesis regulates ER quality control and increases receptor surface
expression. The A2A adenosine receptor binds directly to USP4, a deubiquitinating enzyme,
which results in enhanced cell surface expression of functionally active receptor (93).
UBIQUITIN AND ESCRT-INDEPENDENT LYSOSOMAL SORTING
Several mammalian GPCRs have been reported to sort through the endosomal-lysosomal
system independent of ubiquitination and some components of the ESCRT machinery. A
mutant DOR (δ-opioid receptor) in which all intracellular Lys were changed to Arg undergoes
agonist-promoted degradation similar to the wild-type receptor, suggesting that DOR
ubiquitination is not required for efficient lysosomal sorting (94). Although degradation of
activated DOR is not dependent on ubiquitination, lysosomal sorting occurs through an HRS-
and VPS4-dependent pathway, similar to CXCR4. However, degradation of DOR does not
require TSG101, a component of the ESCRT-I complex, which binds and sorts ubiquitinated
cargo. Interestingly, lysosomal sorting of DOR is mediated by direct interaction with GASP
(GPCR-associated sorting protein) (95). GASP is a large 1395–amino acid cytoplasmic protein
that lacks any known protein-protein interaction domains but contains 22 stretches of 15 acidic
residues in the N-terminal region and a conserved C-terminal domain that is found in 10 related
genes (96). GASP binds to many GPCRs, including those that internalize and efficiently recycle
and/or sort through an ubiquitin-dependent lysosomal degradation pathway, such as the β2AR
(95–97). Interestingly, a recent study indicates that GASP binds to a conserved region within
the putative eighth α-helix of the DOR and β1AR (96), but how GASP functions precisely to
regulate GPCR sorting within the endosomal-lysosomal system is not known (see Reference
38a for further discussion).
PAR1 also sorts from endosomes to lysosomes independent of ubiquitination, HRS, and
TSG101 (56,98), suggesting that PAR1 is targeted to lysosomes through an ESCRT-
independent pathway. A recent study showed that PAR1 is deubiquitinated following
activation and an ubiquitin-defective mutant is degraded comparably to the wild-type receptor
(56). These findings indicate that deubiquitinated rather than ubiquitinated PAR1 transits
through the endosomal-lysosomal system. The sorting of activated PAR1 to lysosomes is
dependent, however, on SNX1 (sorting nexin-1), a protein that localizes to early endosomes
and is known to function in membrane trafficking (99) (Figure 2). Agonist-induced PAR1
lysosomal degradation was impaired by ablation of endogenous SNX1 expression and
disruption of SNX1 localization (98,98a). In addition to PAR1, an in vitro protein-protein
interaction screen using SNX1 and a library of 59 GPCR C-tails revealed that 10 different
GPCRs are capable of interacting with SNX1 (97). SNX1 contains a PX (phox homology)
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domain that binds phosphoinositides and a C-terminal BAR (Bin/Amphiphysin/Rvs) domain
that allows SNX1 to dimerize and to sense membrane curvature (99). SNX1 is likely to regulate
sorting of PAR1 early in the endocytic pathway. SNX1 binds to the tubular portion of early
endosomes and forms oligomers that facilitate the pinching off of endosomal tubules through
a process that likely involves other as-yet unidentified endocytic proteins (99). The identities
of other endocytic adaptor proteins that mediate ubiquitin-independent lysosomal sorting of
PAR1 remain to be determined.
PALMITOYLATION AND GPCR TRAFFICKING
Palmitoylation is a regulated and reversible process that has been reported to affect GPCR
signaling and trafficking. S-palmitoylation of GPCRs occurs through the covalent attachment
of a C16 fatty-acid chain via a thiolester linkage to Cys residues localized within the C-tail of
a GPCR and was first reported for the rhodopsin receptor (100). The atomic resolution structure
of bovine rhodopsin revealed that palmitoylation contributes to the formation of a fourth
intracellular loop that adopts an α-helical structure (101). A large number of GPCRs appear to
be modified with palmitoylation, suggesting a general posttranslational modification. A mutant
β2AR in which Cys-341 was mutated to Gly is not palmitoylated and displays
hyperphosphorylation, constitutive desensitization, and internalization (102), suggesting that
depalmitoylation promotes receptor phosphorylation. Similar findings were observed with the
A3 adenosine receptor and luteinizing hormone receptor, but this is clearly not the case for all
GPCRs (103). Indeed, a mutant form of the chemokine CCR5 receptor that is not palmitoylated
shows a decrease in agonist-promoted phosphorylation and internalization (104). Moreover,
palmitoylation appears to regulate GPCR stability. An A1 adenosine receptor mutant defective
in palmitoylation displayed an increase in receptor degradation during biogenesis but showed
minimal effects on agonist-promoted G-protein activation, internalization or downregulation
(105). A palmitoylation-defective CCR5 receptor mutant was fully functional but showed
decreased surface expression as a result of increased degradation that appears to be mediated
through a lysosomal degradation pathway (106), but whether this involves trafficking from the
cell surface or via the trans-Golgi network to lysosomes was not determined. Recent studies
examining the protein stability of SNAREs (soluble N-ethylmaleimide sensitive factor
attachment protein receptors) in yeast (107) and the anthrax toxin in mammalian cells (108)
indicate that palmitoylation protects these proteins from ubiquitination and subsequent
degradation. The function of palmitoylation in regulation of GPCR ubiquitination, or vice
versa, has not been explored and deserves further investigation.
DYSREGULATED GPCR TRAFFICKING AND DISEASE
Dysregulated GPCR trafficking is associated with several human diseases. Patients with
nephrogenetic diabetes insipidus show reduced or complete loss of renal epithelial V2R surface
expression that has been attributed to multiple V2R mutations that impair trafficking through
the biosynthetic pathway (see review in 109). Similarly, mutations in the GnRH (gonadotropin-
releasing hormone receptor) and rhodopsin result in defective trafficking to the cell surface
and associated human pathophysiological diseases. In addition, many GPCRs are
overexpressed in human cancers and contribute to tumor progression (a topic recently reviewed
in 110). Recent work has revealed that dysregulated trafficking of CXCR4 and PAR1 within
the endosomal-lysosomal system contributes to increased surface expression in breast cancer
cells and cancer progression. A recent study showed that ErbB2 (HER2), an oncogenic tyrosine
kinase, which is overexpressed in ~30% of breast cancers, impairs CXCR4 degradation and
thereby increases its surface expression (111). ErbB2 enhances CXCR4 expression by
increasing protein synthesis and by impairing CXCR4 ubiquitination and lysosomal
degradation through a mechanism that may involve PI-3-kinase activity. As discussed above,
CISK is activated by PI-3-kinase signaling and blocks AIP4-mediated lysosomal sorting and
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degradation of CXCR4 (23), raising the possibility that CISK may contribute to elevated
CXCR4 expression in breast cancer. PAR1 is also overexpressed in malignant breast cancer
(112), and can promote tumor progression through multiple mechanisms (see recent review in
113). In addition to PAR1 overexpression, tumor cells display aberrant PAR1 trafficking,
which causes persistent signaling and cellular invasion (114). These defects appear to be
specific to breast cancer cells, because PAR1 in normal human mammary epithelial cells
displays proper trafficking and signal termination. However, the mechanisms responsible for
defective PAR1 trafficking in breast carcinoma remain to be defined.
CONCLUSIONS AND FUTURE PERSPECTIVES
The GPCR family transduces signals of diverse extracellular stimuli and controls a large
number of physiological responses. Rapid desensitization and receptor trafficking tightly
control the temporal and spatial regulation of GPCR signaling. Given the vast number and
diversity of GPCRs, multiple complex mechanisms likely function to control sorting of distinct
GPCRs within the endosomal-lysosomal system. Many studies have advanced our
understanding of the molecular mechanisms that control GPCR internalization, recycling, and
lysosomal sorting. The discovery that certain GPCRs are recruited to CCPs and internalize
independent of arrestins led to the suggestion that there are other clathrin adaptor proteins that
have critical functions in receptor endocytosis. The presence of short, linear peptide sequences
that are recognized by distinct adaptor proteins within the C-tails of many GPCRs further
suggests that diverse pathways exist for endocytic sorting of certain GPCRs. Indeed, recent
studies have shown a function for C-tail PDZ ligand sequences in GPCR recycling and
internalization. Despite many advances in understanding the function of sorting signals present
in the C-tail of GPCRs, fundamental questions remain regarding the endocytic sorting
machinery and regulatory mechanisms that control trafficking of most GPCRs.
The discovery that mammalian GPCRs are ubiquitinated has added a new challenge to
understanding the mechanisms involved in regulation of GPCR signaling and trafficking. One
function of GPCR ubiquitination is to regulate receptor trafficking to lysosomes, but more
questions remain regarding the nature of the ubiquitin-dependent sorting machinery and how
these dynamic processes are regulated. Recent studies have identified a novel function for
ubiquitination in negative regulation of GPCR internalization, suggesting additional functions
for ubiquitination in the control of GPCR trafficking. GPCR ubiquitination is also likely to
regulate multiple protein-protein interactions and to impact diverse GPCR functions. Future
studies that assess how ubiquitin functions and the mechanisms controlling GPCR
ubiquitination should continue to yield novel insights. In addition to ubiquitin, posttranslational
modification of GPCRs with ubiquitin-like proteins (Ubls), such as sumoylation, is known to
occur (118). The extent GPCR modification with Ubls is not known but is likely to occur and
to profoundly effect receptor function (for more information on Ubls, see the sidebar Ubiquitin-
Like Proteins).
UBIQUITIN-LIKE PROTEINS
In addition to ubiquitin, a number of ubiquitin-like proteins (Ubls), including SUMO,
ISG15, Nedd8, and Atg8, have been found to function in protein modifications (117).
Although ubiquitin and Ubls do not share much primary sequence similarity, all Ubls
possess essentially the same three-dimensional structure, the ubiquitin or β-grasp fold. All
Ubls appear to be covalently linked to substrates via related enzymatic reactions as described
for ubiquitination above. The SUMO consensus site [I/V/L]-K-X-[D/E] is a binding site for
the E2 SUMO-conjugating enzyme Ubc9. SUMO E2 and E1 are sufficient for sumoylation
of target proteins in vitro without an E3, but whether this occurs in vivo is not known. Unlike
ubiquitin modification of GPCRs, the function of Ubls in GPCR signaling and trafficking
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remains relatively unexplored. Sumoylation is known to regulate transcriptional activity
and recent findings suggest a broader role in cell functions outside the nucleus. Pias1, a
SUMO E3 ligase, was found to bind to the mGluR8 C-tail region and mGluR8 was shown
to be sumoylated at Lys-882 within a consensus sequence, but the mechanism and function
of mGluR8 sumoylation remains to be determined (118).
Given the importance of GPCR trafficking in the temporal and spatial control of signaling, it
is critical to understand. Identifying the molecular machinery that regulates endocytic sorting
of distinct GPCRs will enable the development of new strategies to manipulate receptor
signaling and will provide novel targets for the development of drugs that can be used in the
prevention and treatment of a wide range of human diseases. In addition, GPCRs are allosteric
proteins that adopt many distinct conformations, some of which promote receptor
internalization independent of G-protein activation (118a). The identification of new drugs
(termed allosteric modulators) that promote GPCR internalization independent of cellular
signaling could be potentially useful therapeutics for certain disease scenarios. It will be
important to determine how some current drugs modulate GPCR trafficking to provide a better
understanding of their beneficial and untoward effects.
SUMMARY POINTS
1. The sorting of activated GPCRs to lysosomes for degradation occurs through
ubiquitin-dependent and -independent pathways.
2. The recycling of GPCRs occurs through bulk membrane flow or through a
regulated process that involves PDZ ligand sequences.
3. The sorting of GPCRs on endosomes is a highly regulated process involving many
proteins and it controls the amount of receptor present on the cell surface and
hormone responsiveness.
4. Short, linear peptide sequences and/or posttranslational modifications determine
the endocytic pathway followed by GPCRs.
5. Posttranslational modifications of GPCRs regulate the quality control and
trafficking within the early biosynthetic pathway.
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150-nm structures that occupy ~2% of the plasma membrane and




endosomal protein complexes originally identified in yeast that
support transport of ubiquitinated cargo into intraluminal
vesicles of multivesicular bodies
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a clathrin adaptor complex composed of α, β2, μ2, and σ2
subunits, which recognize short linear peptide sequences
CISK cytokine-independent survival kinase
AIP4 atrophin-interacting protein-4
Downregulation a process in which the cell decreases the number of receptors to
a given hormone to reduce its sensitivity to this molecule
NSF N-ethylmaleimide sensitive factor




a microscopy technique that increases the spatial resolution of
specimens located at or within 100 nm of the plasma membrane
DUB deubiquitinating enzyme
AMSH associated-molecule with the SH3 domain of STAM
STAM signal transducing adaptor molecule
Multivesicular bodies
(MVBs)
a distinct endosomal compartment containing intralumenal
vesicles that fuse with lysosomes resulting in degradation of
vesicles and transmembrane proteins
TSG101 tumor suppressor gene product 101
GASP GPCR-associated sorting protein
SNX1 sorting nexin-1
Desensitization a process that results in the loss of responsiveness of a signaling
system to the continuing or increasing dose of a hormone or drug
SNARE soluble N-ethylmaleimide sensitive factor attachment protein
receptor
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Model of GPCR recruitment to clathrin-coated pits (CCPs). The clathrin adaptor AP-2 is first
recruited to the plasma membrane at sites enriched in PIP2 and facilitates the recruitment of
more AP-2, clathrin, and alternate clathrin adaptors. Many activated GPCRs are
phosphorylated and bind arrestins, which facilitates recruitment into the nascent CCPs. Other
GPCRs harbor short linear peptide sequences or are modified with ubiquitin and recognized
by alternate clathrin adaptors. The newly formed CCPs gradually invaginate and pinch off from
the plasma membrane through the actions of the GTPase dynamin to form a vesicle. Many
other accessory proteins and alternate clathrin adaptors are also present in the nascent and
forming CCPs.
Marchese et al. Page 21














G protein–coupled receptor trafficking within the endosomal-lysosomal system. Several
studies indicate that distinct mechanisms control trafficking of different mammalian GPCRs.
(a) PAR1 displays constitutive and agonist-induced internalization that occur independent of
arrestins and is differentially regulated by ubiquitination. Constitutive internalization of PAR1
requires AP-2 and is negatively regulated by ubiquitination. Activated PAR1 is
phosphorylated, rapidly internalized, and sorted from endosomes to lysosomes through a
SNX1-dependent pathway, which is independent of HRS and TSG101, a component of the
ESCRT-I machinery. Whether PAR1 enters MVBs (multivesicular bodies) or sorts directly to
lysosomes is not known. (b) Activated CXCR4 is ubiquitinated at the plasma membrane by
the E3 ubiquitin ligase AIP4. Ubiquitination functions as an endosomal sorting signal and is
not required for CXCR4 internalization. Ubiquitinated CXCR4 is concentrated on HRS-
positive microdomains together with AIP4. AIP4 mediates ubiquitination of HRS following
CXCR4 activation, which is critical for MVB sorting. CISK phosphorylates and inhibits AIP4
activity and thereby inhibits endosomal sorting of CXCR4. VPS4 also regulates the
ubiquitination status of CXCR4 and MVB sorting. (c) Agonist induces rapid phosphorylation
and ubiquitination of the β2AR. Arrestin-3 is ubiquitinated by MDM2 and recruited to activated
β2AR, a process required for β2AR internalization. Once internalized, β2AR are
dephosphorylated and rapidly recycled back to the plasma membrane through a pathway that
involves EBP50/NHERF, NSF, and HRS. Whether deubiquitination of β2AR is involved in
the regulated mode of receptor recycling is not known. After prolonged agonist exposure,
activated β2AR sorts from endosome to lysosomes and are degraded through an ubiquitin-
dependent mechanism.
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The ubiquitin modification of proteins. Ubiquitin (Ub) is attached to its target protein by the
sequential action of E1, E2, and E3 enzymes. The E1 (activating enzyme) first activates
ubiquitin in an ATP-dependent reaction by forming a thioester bond at its active-site cysteine
with the COOH-terminus of ubiquitin. Ubiquitin is then transferred to the active site cysteine
of the E2 (conjugating enzyme). The last step is catalyzed by either an E2 with the help of an
E3 (RING-finger) or directly by an E3 (HECT-domain), leading to the transfer of ubiquitin to
an epsilon amino group of a lysine residue on the target protein forming an isopeptide bond
with the C-terminal glycine of ubiquitin. A single ubiquitin can be attached to proteins (Mono
Ub) at a single and/or multiple lysine residues on the target protein. Alternatively multiple
ubiquitins can be attached to one another forming poly Ub chains (Poly Ub), typically via lysine
48 or 63 linkages. Ubiquitin is removed from target proteins by the action of deubiquitinating
enzymes (DUBs).
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Table 1
Alignment of human GPCR C-tail sequences containing serine and threonine clusters
See Supplemental Appendix 1 for a description of how the list of human GPCR C-tails with serine and threonine clusters in this table and other motifs
in other tables were acquired and amino acid designations (follow the Supplemental Material link from the Annual Reviews home page at
http://www.annualreviews.org). The serine and threonine clusters are shaded in grey and critical residues are shown in red. Abbreviations used: CCK,
cholecystokinin; GnRH, gonadotropin-releasing hormone; LPL, lysophospholipid; N-FMLP, N-Formylpeptide; PAR, protease-activated receptor.
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Table 2
Alignment of human GPCR C-tail sequences containing tyrosine-based motifs
A search for human GPCR C-tail sequences containing tyrosine-based motifs that conformed to Y-X-X-Ø, where Y denotes tyrosine, X is any amino
acid, and Ø is a bulky hydrophobic residue (W, L, I, F, V, M) was completed as described in Supplemental Appendix 1. The acidic di-leucine-based
motif is shaded in grey and the critical residues are shown in red or green. Abbreviations used: 5-HT, 5-hydroxytryptamine; GnRH, gonadotropin-
releasing hormone; GLYC-H, glycoprotein-hormone; PAR, protease-activated receptor; TRH, thyrotropin-releasing hormone.
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Table 3
Alignment of human GPCR C-tails sequences containing acidic di-leucine based motifs
A search for human GPCR C-tail sequences containing acidic di-leucine based motifs that conform to [D/E]-X-X-X-L-[L/I] or [D/E]-X X-L-[L/I]
was completed as described in Supplemental Appendix 1. The acidic di-leucine-based motif is shaded in grey and the critical residues are shown in
red or green. Abbreviations used: FFA, free fatty acid; GLYC-H, glycoprotein-hormone; RFP, relaxin family peptide; PRP, prolactin-releasing peptide;
SPC/LPC, (lyso)Phospholipid mediators; 5-HT, 5-hydroxytryptamine.













Marchese et al. Page 27
Table 4
Alignment of human GPCR C-tail sequences containing PDZ ligands
A search for human GPCR C-tail sequences containing PDZ ligands that conform to Type I X-[S/T]-X-[φ]; Type II X-[φ]-X- [φ]; Type III X-[D/E]-
X-[φ], where X is any amino acid and φ is a bulky hydrophobic residue (W, L, I, F, V, M) was completed as described in Table 1. Of these several
sequences were confirmed to be known GPCRs (excluding sensory and orphan receptors and psuedogenes) and aligned starting with the [N/D]
PX2-3Y-like motif. The mGluR C-tail sequences were added separately. The PDZ ligand sequence is shaded in grey and the critical residues are
shown in color. In some cases, numbers of amino acids were omitted either before or after the motif and are shown in parentheses. The period indicates
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the end of the C-tail sequence. The list includes the GPCR family name and nomenclature according to the International Union of Pharmacology
(IUPHAR) (Foord et al. Pharmacol Rev. 2003, 55:587-9) and the Swiss-Protein accession number (http://ca.expasy.org/sprot/). Abbreviations used:
5-HT, 5-hydroxytryptamine; FFA, free fatty acid; LT/LX, leukotriene and lipoxin; LPL, lysophospholipid; MCH, melanin-concentrating hormone;
PRP, prolactin-releasing peptide; mGluR, metabotropic-glutamate receptor.
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